Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

BACKGROUND: Sclerostin is a Wnt pathway antagonist regulating osteoblast activity and bone turnover. Here, we assessed the potential association of sclerostin with the development of coronary artery (CAC) and aortic valve calcifications (AVC) in haemodialysis (HD) patients. METHODS: We conducted a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Brandenburg, Vincent M, Kramann, Rafael, Koos, Ralf, Krüger, Thilo, Schurgers, Leon, Mühlenbruch, Georg, Hübner, Sinah, Gladziwa, Ulrich, Drechsler, Christiane, Ketteler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851854/
https://www.ncbi.nlm.nih.gov/pubmed/24112318
http://dx.doi.org/10.1186/1471-2369-14-219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851854/
https://www.ncbi.nlm.nih.gov/pubmed/24112318
http://dx.doi.org/10.1186/1471-2369-14-219

Ejemplares similares